Pharma Pulse 9/24/24: The Financial Benefits of Technology, Empathy Left Outside the Exam Room Door & more

The Financial Benefits of Technology

In the final part of his interview with Pharma Commerce Editor Nicholas Saraceno, Kevin MacDonald, Bluesight’s Co-founder and CEO, explains the amount of time it takes to see a reduction in annualized drug spend, and offers estimates in terms of percent savings.

What Diabetes Taught Me That Pharmacy School Did Not

Empathy is being left outside the exam room door.

Will A.I. Be a Bust? A Wall Street Skeptic Rings the Alarm.

Jim Covello, Goldman Sachs’s head of stock research, warned that building too much of what the world doesn’t need “typically ends badly.”

Kenvue Drives Climate Action Strategy Forward

Kenvue Inc., the maker of iconic brands such as Aveeno®, Listerine®, Neutrogena® and Tylenol®, is advancing progress toward the climate change goals outlined in its Healthy Lives Mission environmental, social and governance strategy, including releasing its first Task Force on Climate-related Financial Disclosures (TCFD) report.

Robert Minicucci (He/Him) on LinkedIn

This Pharmaceutical Executive makes a great point about the importance of senior leader engagement on social media. Like it or not, such engagement is becoming a larger part of the job requirements of company leaders -- great way to build brand authenticity.

👉 A Risk-Reward Reset: Getting Serious About #SocialMedia
https://lnkd.in/gUyTZwE7

#pharmamarketing #biopharma #biotech

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs